首页 | 本学科首页   官方微博 | 高级检索  
     


Multifactorial treatment of hypertensive men at high cardiovascular risk and low-density lipoprotein cholesterol affinity to human arterial proteoglycans
Authors:B. FAGERBERG,O. WIKLUND,S. AGEWALL,G. CAMEJO,&   R. J. WIKSTRAND
Affiliation:Department of Medicine and the;Wallenberg Laboratory for Cardiovascular Research, Sahlgrenska University Hospital, Göteborg University, Göteborg, and;Biochemistry, Preclinical Research Laboratories, Astra Hässle, Mölndal, Sweden
Abstract:The purpose of this work was to examine in an open, randomized parallel-group study whether an intervention programme directed towards hypercholesterolaemia, smoking and diabetes mellitus in treated hypertensive men was associated with less complex formation between low-density lipoprotein (LDL) and human arterial proteoglycans than was the case with usual care. The intervention consisted mainly of non-pharmacological treatment, but drug therapy could be instituted to achieve the treatment goals in the intervention group. The intervention programme was associated with a significant reduction in body mass index, and 46% of the patients were on lipid-lowering medication at the follow-up examination. The net differences were (intervention − usual care): change in serum LDL-cholesterol, −0.48 mmol L−1 (95% confidence interval −0.84 to −0.11 mmol L−1), precipitated LDL-cholesterol, −5.5 μg (95% CI −9.0 to −1.1 μg). The latter remained after adjustment for the difference in serum LDL-cholesterol between the groups. Our conclusion is that the multifactorial risk factor treatment programme was associated with a reduced tendency of LDL to form complexes with human arterial proteoglycans.
Keywords:Atherosclerosis    diet    hyperlipidaemia    hypertension    intervention    proteoglycan
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号